6-氯-9-(2,3,5-三-O-苯甲酰基-2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤-2-胺
| 中文名称 | 6-氯-9-(2,3,5-三-O-苯甲酰基-2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤-2-胺 |
|---|---|
| 中文同义词 | 6-氯-9-(2,3,5-三-O-苯甲酰基-2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤-2-胺;(2R,3R,4R,5R)-2-(2-氨基-6-氯-9H-嘌呤-9-基)-5-((苯甲酰氧基)甲基)-3-甲基四氢呋喃-3,4-叉基二苯酸盐;(2R,3R,4R,5R)-2-(2-氨基-6-氯-9H-嘌呤-9-基)-5-((苯甲酰氧基)甲基)-3-甲基四氢呋喃-3,4-二基二苯甲酸酯;2-氨基-6-氯-9-[(2,3,5-三-O-苯甲酰基-2-甲基-Β-D-呋喃核糖基)]-9H-嘌呤;化合物 2-AMINO-6-CHLORO-9-[(2,3,5-TRI-O-BENZOYL-2-C-METHYL-Β-D-RIBOFURANOSYL)]-9H-PURINE;[2-氨基-6-氯-9-[(2,3,5-三-(O)-苯甲酰基-2-β-C-甲基-β-D-呋喃核糖基)]-9H-嘌呤] |
| 英文名称 | 2-AMino-6-chloro-9-[(2,3,5-tri-O-benzoyl- 2-C-Methyl-β-D-ribofuranosyl)]-9H-purine |
| 英文同义词 | 2-AMino-6-chloro-9-[(2,3,5-tri-O-benzoyl- 2-C-Methyl-β-D-ribofuranosyl)]-9H-purine;(2R,3R,4R,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-((benzoyloxy)methyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate;(3R,4R,5R)-2-(2-amino-6-chloro-9H-purin-9-yl)-5-((benzoyloxy)methyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate;9H-Purin-2-amine, 6-chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-;2-Amino-6-chloro-9-(2-C-methyl)-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)]-9H-purine;6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purin-2-amine;2-C-Methyl-β-D-ribofuranosyl)]-9H-purine;2-AMino-6-chloro-9-[(2,3,5-tri-O-benzoyl- |
| CAS号 | 641571-44-0 |
| 分子式 | C32H26ClN5O7 |
| 分子量 | 628.03114 |
| EINECS号 | |
| 相关类别 | 核苷 |
| Mol文件 | 641571-44-0.mol |
| 结构式 |  |
6-氯-9-(2,3,5-三-O-苯甲酰基-2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤-2-胺 性质
6-氯-9-(2,3,5-三-O-苯甲酰基-2-C-甲基-BETA-D-呋喃核糖基)-9H-嘌呤-2-胺 是一种腺嘌呤核苷类似物。腺苷类似物大多可作为平滑肌血管扩张剂，也被证明能够抑制癌症进展。它的热门产品有 Adenosine phosphate，Acadesine (HY-13417)，Clofarabine (HY-A0005)，Fludarabine phosphate (HY-B0028) 和 Vidarabine (HY-B0277)。